Home › Arrhythmogenic Right Ventricular Dysplasia › California
Arrhythmogenic Right Ventricular Dysplasia clinical trials in California
4 studies for Arrhythmogenic Right Ventricular Dysplasia are looking for participants at sites in California.
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
- University of California, San Diego, La Jolla
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT05885412A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
- Leland Stanford Junior University, Redwood City
RecruitingObservational study
Ages 18 to 65 · All sexes · Updated May 16, 2025 · NCT06976606Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
- University of California San Francisco, San Francisco
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Feb 6, 2025 · NCT06228924Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- University of California San Francisco, San Francisco
RecruitingObservational study
Ages 14 to 65 · All sexes · Updated Nov 1, 2024 · NCT06311708From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.